Microneedling and Topical Actives: A Practical Guide
Published by AmpleLab Research
Microneedling is one of the most widely used adjunct techniques in the hair loss community. It has a reasonable evidence base for scalp use, a coherent mechanistic rationale, and it is accessible as a home practice in a way that most clinical interventions are not. It is also one of the areas where the wrong topical active, applied at the wrong time, can turn a beneficial protocol into an irritating one.
This article covers what microneedling does, what the evidence shows for its use in hair loss, how to approach needle length and frequency, and which topical actives make sense to use alongside it, and which do not. The article on using copper peptides and minoxidil together is a useful companion piece for those combining both actives in a protocol.
Microneedling creates controlled micro-injuries in the skin or scalp using fine needles arranged in a roller, stamp, or motorised pen. The injuries are small enough to heal rapidly but large enough to trigger the skin's wound-healing cascade: platelet activation, growth factor release (including VEGF, PDGF, and TGF-beta), increased local blood flow, and the activation of dermal fibroblasts and keratinocytes.
For the scalp specifically, two effects are relevant to hair loss. The first is the direct biological response: growth factor release, increased perifollicular blood flow, and possible activation of stem cells in the follicle bulge region, which is proposed as one mechanism by which microneedling may promote anagen entry. The second is enhanced topical absorption: the micro-channels created by the needles temporarily bypass the stratum corneum barrier, increasing the penetration of topical actives applied immediately after.
These two effects are related but distinct. A microneedling session provides biological benefit whether or not a topical is applied. Applying the right topical immediately after amplifies that benefit by increasing delivery of the active to the follicle level. Applying the wrong topical introduces irritants directly into compromised skin.
The most-cited clinical study on scalp microneedling for hair loss is Dhurat et al. 2013, published in the International Journal of Trichology. The study randomised 100 men with androgenetic alopecia to either minoxidil 5% alone or minoxidil 5% combined with weekly microneedling at 1.5mm. After 12 weeks, the microneedling group showed significantly greater mean hair count increase compared to the minoxidil-only group. Patient satisfaction scores were also substantially higher in the combination group.
The proposed mechanisms in that study included upregulation of hair growth-related genes including VEGF, beta-catenin, and Wnt3a and Wnt10b, consistent with stem cell activation and anagen promotion. Subsequent smaller studies have broadly supported the finding that microneedling adds benefit over minoxidil alone, though the evidence base remains limited by study size and duration.
On the Evidence
The evidence for scalp microneedling in androgenetic alopecia is promising but based on a relatively small number of controlled studies. It is best understood as a well-reasoned adjunct to established treatments rather than a standalone intervention with a large clinical evidence base.
For users already using minoxidil, copper peptides, or other topical actives, adding microneedling appears to increase the effectiveness of those treatments through enhanced absorption and the direct biological effects described above. It is also accessible: home dermarollers and dermastamps at appropriate needle lengths are widely available and safe for self-use when basic hygiene practices are followed.
Needle length determines the depth of penetration, the intensity of the wound-healing response, and the degree of enhanced topical absorption. Frequency should decrease as needle length increases, to allow adequate skin recovery between sessions.
Surface stimulation Β· Daily use possible
Minimal penetration depth. Suitable for daily use to maintain scalp stimulation and enhance absorption of daily topicals. Less likely to produce a significant wound-healing response but useful as a high-frequency adjunct.
Standard absorption enhancement Β· 2β3x per week
The most commonly recommended length for home scalp use to enhance topical absorption. Reaches the upper dermis, providing meaningful absorption enhancement and a moderate wound-healing signal. Allow at least 24 to 48 hours between sessions.
Follicle-level stimulation Β· Once per week or less
Reaches mid-dermis and produces a more pronounced wound-healing response. The Dhurat et al. study used 1.5mm at weekly intervals; 1.0mm is a more cautious entry point for this depth range. Scalp should be allowed to fully recover between sessions.
Clinical depth Β· Professional context recommended
The depth used in the primary clinical studies. At this length, the procedure enters territory where professional guidance is advisable. Risk of post-inflammatory hyperpigmentation and infection increases if sterile technique is not maintained. Not recommended for unsupervised home use.
Immediately after microneedling, the skin's barrier function is temporarily compromised and absorption is significantly enhanced. This is the window in which topical actives are most efficiently delivered. It is also the window in which anything irritating, sensitising, or poorly formulated causes the most harm. The general principle is straightforward: apply actives you want to absorb deeply; avoid anything that would cause problems at higher-than-normal skin concentrations.
Appropriate for Post-Microneedling Application
1% GHK-Cu Face and Skin Serum / 1% AHK-Cu Hair and Scalp Serum
Water-based, pH-neutral, and specifically relevant to follicle health. The enhanced absorption window increases delivery of the peptide-copper complex past the stratum corneum, which is otherwise a barrier for hydrophilic molecules. Glycol-free formulations are preferable for post-microneedling use.
Water-soluble, non-irritating, and angiogenically active. The vascular mechanism of 2dDR is relevant to the perifollicular microenvironment that microneedling also targets, making the combination mechanistically coherent. Apply to a clean, dry scalp immediately post-session.
Minoxidil
The Dhurat 2013 study applied minoxidil after microneedling sessions, and the combination showed superior outcomes to minoxidil alone. However, opinions differ among practitioners regarding immediate post-microneedling application: enhanced absorption increases both the potential benefit and the risk of scalp irritation and elevated systemic exposure. Some clinicians recommend waiting 12 to 24 hours after microneedling before applying minoxidil, particularly at longer needle lengths. If you use minoxidil and experience increased irritation when applying it post-session, allowing recovery time before application is a sensible adjustment.
Saline or plain water
If you are not applying an active immediately after, rinsing with sterile saline or clean water and leaving the scalp bare is preferable to applying a product you would not normally want to absorb deeply.
Avoid Immediately After Microneedling
Retinoids (retinol, tretinoin)
Retinoids are irritating to compromised skin at standard concentrations and significantly more so when absorbed past the normal barrier. Increased retinoid absorption through microneedled skin can cause significant irritation, purging, and post-inflammatory hyperpigmentation. Avoid on the day of microneedling and ideally 24 hours either side.
Alpha and beta hydroxy acids (AHAs, BHAs)
Glycolic acid, salicylic acid, and similar exfoliating acids are appropriate for intact skin at defined concentrations. Applied through microneedle channels, those concentrations can cause chemical burn-equivalent effects on dermal tissue. Not appropriate for post-microneedling application.
High-concentration vitamin C (ascorbic acid)
Vitamin C serums at 10 to 20% ascorbic acid are formulated for application to intact skin. The acidity and oxidative activity at those concentrations may cause significant irritation on microneedled skin. Lower-concentration or buffered vitamin C derivatives are safer, but the post-microneedling window is not the right time for this active.
Glycol-containing products
Propylene glycol, butylene glycol, and related solvents are common in many serums and are generally well tolerated on intact skin. Through microneedle channels, those solvents penetrate more deeply than they would normally, increasing the risk of irritation for users with glycol sensitivity. This is particularly relevant for scalp use, where the skin is already often sensitised.
Fragranced or alcohol-containing products
Both fragrance and denatured alcohol (alcohol denat.) are common in scalp tonics, sprays, and some serums. Both are irritating to compromised skin. Fragrance contains a wide range of potential allergens; alcohol denat. disrupts the skin barrier further. Neither is appropriate for post-microneedling application.
For a microneedling session followed by topical actives, the sequence matters.
after Apply chosen topical active to the treated area. This is one of the periods of greatest enhanced absorption. Copper peptides and 2dDR are generally well suited to immediate post-microneedling application. Minoxidil protocols vary; see the note above. Leave on; do not rinse.
Microneedling is not appropriate in all circumstances. The following are reasons to pause or avoid:
Introducing a contaminated needle into skin with a compromised barrier is the primary risk of home microneedling. Basic hygiene eliminates most of this risk.
A randomised evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study
Dhurat R et al. β International Journal of Trichology, 2013 PubMed β
Microneedling in androgenetic alopecia; comparing two microneedling devices with different needle configurations
Dhurat R, Mathapati S β Journal of Clinical and Aesthetic Dermatology, 2015 PubMed β
Should I use a dermaroller or a dermastamp?
Both are effective. Dermarollers cover larger areas more quickly and are well-suited to full-scalp treatment. Dermastamps allow more precise targeting of specific areas and cause less lateral skin traction, which some users find more comfortable, particularly at longer needle lengths. For most home users a 0.5mm dermaroller is a practical starting point; dermastamps are worth considering for more focal application at higher needle lengths.
How much bleeding is normal?
At 0.25mm to 0.5mm, no bleeding should occur or it should be minimal pinpoint bleeding. At 1.0mm some pinpoint bleeding can occur, particularly on the first few sessions. Significant bleeding, prolonged bleeding, or bleeding across a large area is a signal that pressure is too high, frequency is too high, or the skin has not fully recovered from a previous session. Scale back if this occurs.
Can I microneedle and use minoxidil on the same days I don't microneedle?
Yes. On non-microneedling days, minoxidil and topical actives are applied to intact skin as normal. The microneedling sessions provide periodic enhancement on top of the daily baseline. Most protocols use microneedling once or twice a week and continue daily topical application on the remaining days.
Will microneedling make my hair loss worse initially?
Some users report a temporary increase in shedding when starting microneedling, particularly at higher frequencies or needle lengths. This may reflect the displacement of telogen hairs by new anagen growth stimulated by the procedure, which is the same phenomenon seen when starting minoxidil. If shedding is significant or persistent beyond the first few weeks, reducing frequency or needle length and monitoring is advisable.
How long before microneedling shows results?
The Dhurat 2013 study used a 12-week protocol and saw significant differences at that point. As with any intervention that works through the hair growth cycle, meaningful assessment requires several months. The 6-month benchmark discussed in the results timeline article applies here: the cycle biology means visible results take time regardless of whether the underlying stimulus is working.
This article is provided for educational purposes. AmpleLab products are cosmetic formulations and are not intended to diagnose, treat, cure, or prevent any condition. Consult a qualified healthcare professional before beginning any new treatment protocol, particularly if you have an existing scalp condition.
AmpleLab.